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Abstract A lipid-binding protein identical to the rat intestinal 
bile acid-binding protein, termed 1-15P, was expressed in steroid 
hormone-producing tissues such as ovary and adrenal gland, but 
not testis. In immature rats, 1-15P was expressed in intestine but 
not in ovaries. The expression of 1-15P in the ovaries of immature 
rats was induced to the level in immature rats by gonadotropin 
treatment. This suggests that the expression of 1-15P in the 
ovaries is controlled by the ovarian cycle. The present results 
indicate that the expression of 1-15P is developmentally and 
hormonally controlled in a tissue-specific manner. 
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1. Introduction 
Fatty acid-binding proteins (FABPs) are known to exhibit 
high affinity for long chain fatty acids [1,2]. FABPs have similar 
molecular masses (14-15 kDa), and form a family with other 
hydrophobic ligand-binding proteins such as cellular retinol- 
binding protein (CRBP), cellular retinoic acid-binding protein 
(CRABP), and myelin P2 protein (mP2) [3]. To date, at least 
fifteen members of the lipid-binding protein family have been 
isolated from various sources [4]. Although they are thought o 
be involved in the intracellular transport and/or metabolism of 
hydrophobic ligands which are responsible for cellular func- 
tions, their precise functions are not fully understood. 
The intestinal 15 kDa protein (I-15P), a cytosolic protein 
with an apparent molecular mass of 15 kDa, was isolated orig- 
inally from ileal mucosa along with intestine (I-) and liver (L-) 
FABPs [5]. In a previous study, although sequence analysis 
demonstrated that 1-15P is a member of the FABP family, an 
in vitro binding assay revealed it has no binding ability as to 
long chain fatty acids [5]. More recently, we and another group 
have reported that the rat [6] or human homologue [7] of I-15P 
can bind to taurocholate, suggesting that 1-15P may play a role 
in bile acid reabsorption in the ileum. However, the tissue 
distribution of 1-15P, assessed by means of Northern blot and 
immunochemical nalyses, revealed that I-15P was abundantly 
expressed not only in ileum but also in ovaries [8 10]. This 
tissue distribution implies that 1-15P may also be involved in 
steroid metabolism, and raises the questions of the specific 
ligand and function of I- 15P in extra-intestinal organs. Alterna- 
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tively, it is possible that 1-15P expressed in steroid hormone- 
producing tissues is a distinct protein homologous to the intes- 
tinal counterpart, which has a different ligand-binding specific- 
ity. 
In the present study, to address these questions, we identified 
a cDNA for extra-intestinal 1-15P, and examined whether or 
not the expression of 1-15P is developmentally or hormonally 
controlled in a tissue-specific manner. 
2. Materials and methods 
2.1. Hormone treatment 
Immature female Sprague Dawly rats (21 days old) were injected 
subcutaneously with 50 IU of pregnant mare serum gonadotropin 
(PMSG; UCB Bioproducts S.A.) or the vehicle (phosphate-buffered 
saline) alone, followed by the injection of 100 IU of human chorionic 
gonadotropin (hCG; Teikokuzoki) or the vehicle alone after 48 h. Two 
days after the injection of hCG, ovaries and intestines were removed 
from rats killed by means of ether inhalation. The organs were rapidly 
dissected out and quickly frozen in liquid nitrogen, and then stored at 
-80°C until use. Mature female rats (8 weeks old) were used for 
comparison with the immature rats. 
2.2. Molecular cloning of ovarian 1-15P 
A rat ovary cDNA library (Clontech) was screened with a 32p-labeled 
full length rat 1-15P cDNA [8]. Positive clones were isolated and se- 
quenced on both strands by the dideoxy termination method [11] with 
a 373A DNA Sequencer (Applied Biosystems). 
2.3. Reverse transcription-polymerase chain reaction (RT-PCR) 
As described previously [7,12], first-strand cDNAs were synthesized, 
using l/ lg of total cellular RNA prepared from ileum, ovaries, adrenal 
glands or testes of mature rats, according to the manufacturer's proto- 
col (lst-Strand cDNA Synthesis Kit; Clontech). Aliquots (2/zl each) 
were used as templates for PCR amplification specific for rat I-15E The 
primers used were synthesized on the basis of the nucleotide sequences 
of the N-terminal (residues 1 21) and C-terminal (residues 357-384) 
regions [8]. Amplification was performed in a 100/zl reaction mixture 
for 35 cycles; each cycle consisted of I min denaturation at94°C, 2 min 
annealing at 60°C, and 3 min elongation at 72°C, followed by 5 min 
extension at 72°C. As a negative control, the reaction mixture con- 
tained no 1 st-cDNA as a template. The PCR products were separated 
by 2% agarose gel electrophoresis, and then analyzed by Southern 
blotting using the internal probe. To further confirm the identity of the 
PCR products, the amplified DNA fragments prepared from agarose 
gel were ligated into the pGEM-T vector (Promega) and sequenced on 
both strands. Rat glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) cDNA was used as a control. The primers used were based 
on the nucleotide sequences of the upstream (residues 35-60) and down- 
stream (residues 994-1017) regions of rat GAPDH cDNA [13]. Ampli- 
fication of GAPDH cDNA for each tissue was performed as described 
above. 
2.4. Western blot analysis 
Five grams of each organ (ovaries and intestines) was homogenized 
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in 15 ml of 50 mM Tris-HC1, pH 7.5, containing 150 mM KC1 and 0.1 
mM dithiothreitol. The homogenates were centrifuged at 20,000 x g for 
20 min. The resulting supernatants were centrifuged at 105,000 × g for 
60 min to yield the cytosolic fraction. The cytosolic proteins (10 #g) 
were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis and then electroblotted onto nitrocellulose membranes. 
1-15P was detected using anti-rat 1-15P rabbit serum (diluted 1:500). 
As described previously [14], rat heart-type (H)-FABP was detected 
using a specific polyclonal antibody raised against the purified H- 
FABP. After incubation with the first antibodies at 37°C for 1 h, the 
nitrocellulose membranes were incubated with peroxidase-conjugated 
anti-rabbit IgG (diluted 1:400). Peroxidase labeling was detected as 
chemiluminescence using the ECL reagent (Amersham). The signals 
were visualized by exposure to Fuji RX film. 
2.5. Northern blot analysis 
Organs (ovaries and intestines) from control or hormone-treated rats 
were rapidly dissected oat and quickly frozen in liquid nitrogen. Poly 
(A) ÷ RNA was isolated by the method previously reported [8] and then 
fractionated by electrophoresis in a 1% agarose gel containing formal- 
dehyde. After transfer to a NYTRAN nylon membrane (Schleicher and 
Schuell), hybridization was performed with 32P-labeled I-15P cDNA or 
H-FABP cDNA. As described previously [15], H-FABP cDNA, as a 
probe, was synthesized by RT-PCR using the primers corresponding 
to the C-terminal and N-terminal regions on the basis of the H-FABP 
cDNA sequence. Hybridization was performed at 55°C in 5 x SSPE 
(0,9 M sodium chloride/50 mM sodium phosphate/5 mM EDTA, pH 
7.0), 0.1% SDS, 100 #g/ml denatured sonicated salmon sperm DNA 
and 5 x Denhard't solution. The membrane was washed in 1 x SSC 
(0.15 M sodium chloride/0.015 M sodium citrate, pH 7.0) at 65°C, 
followed by visualization. After removing the 1-15P probe, the same 
membrane was reprobed with the H-FABP cDNA. 
3. Results and discussion 
In a previous tudy, Northern blot analysis of rat 1-15P under 
a moderately stringent conditions revealed a single transcript 
only in ileum and ovary [8], however, the RT-PCR in the pres- 
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Fig. 1. RT-PCR of mRNA from steroid hormone-producing tissues. 
First-strand cDNAs of rat ileum, ovary, adrenal gland and testis were 
synthesized, and used as templates for PCR specific for rat 1-15P or 
GAPDH. Upper panels, ethidium bromide staining of the amplified 
products of 1-15R The arrow indicates a 384 bp fragment. Lower 
panels, ethidium bromide staining of the amplified products of 
GAPDH. The arrow indicates a 983 bp fragment. Lane 1, ileum; lane 
2, ovary; lane 3, adrenal gland; lane 4, testis; lane 5, ¢X174/HaeIII. 
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Fig. 2. Western blot analysis of ovarian or intestinal I-15P and ovarian 
H-FABP after treatment of immature rats with gonadotropins. Im- 
munoblot analysis of ovarian or intestine cytosolic 1-15P, and ovarian 
cytosolic H-FABP (10 #g each) in immature rats with anti-rat 1-15P 
(lanes 1-5) or H-FABP antiserum (lanes 6 and 7) was performed. 
Samples were fractionated and subjected to Western blot analysis as 
described in section 2. Lane 1, untreated intestine; lane 2, treated intes- 
tine; lanes 3 and 6, untreated ovary; lanes 4 and 7, treated ovary; lane 
5, untreated mature rat ovary. 
ent study demonstrated expression in other steroid hormone- 
producing tissues such as adrenal gland, but not in testis (Fig. 
1). Therefore, it is possible that a potent lipid-binding protein 
homologous or identical to I-15P is present in these tissues, but 
its precise primary structure and specific ligand are not known. 
To establish the nucleotide identity between intestinal and 
extra-intestinal 1-15P, we performed molecular cloning of 
extra-intestinal 1-15P cDNA. Screening of the 2 x 105 clones 
from the rat ovary cDNA library with the full length rat 1-15P 
cDNA probe yielded several positive clones. The cDNA inserts 
obtained from these positive clones were isolated. One of these 
clones contained a 507 bp nucleotide with a single open reading 
frame encoding 384 bp, as well as 5' (35 bp) and 3' (88 bp) 
untranslated regions (data not shown). It was demonstrated 
that the primary nucleotide sequence of the open reading frame 
of the ovarian counterpart was identical to that of 1-15P in 
intestine. In addition, RT-PCR of adrenal gland revealed that 
the protein expressed in this tissue was also identical to 1-15P, 
but the level was much lower than in ileum or ovary (data not 
shown). Interestingly, although the reason for the lack of ex- 
pression of 1-15P in testis is unknown, it is possible that 1-15P 
specifically plays a role in ovary but not in testis. 
Next, to investigate the function of I-15P in steroid hormone- 
producing tissues, we examined whether or not the ovarian 
1-15P is developmentally or hormonally controlled. We first 
examined the expression of 1-15P in the intestine or ovaries of 
immature rats. As shown in Fig. 2, lanes 1 and 3, Western blot 
analysis revealed that I- 15P was expressed in the intestine of the 
immature female rats but not in ovaries. On the other hand, 
another member of the FABP family, H-FABP, which is local- 
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Fig. 3. Northern blot analysis of ovarian 1-15P and H-FABP mRNA 
after treatment of immature rats with gonadotropins. Two/zg of ovar- 
ian poly (A) ÷ RNA isolated from untreated or gonadotropin-treated 
rats was electrophoresed and then transferred to a nylon membrane. 
The membrane was probed with the full length rat 1-15P cDNA (lanes 
1-3) or H-FABP cDNA (lanes 4 and 5). Lanes 1 and 4, untreated 
immature rat; lanes 2 and 5, treated immature rat; lane 3, untreated 
mature rat. The arrow indicates 1-15P or H-FABP transcript. 
ized in the interstitial cells of rat ovaries [16], was found to be 
expressed even in immature rats (Fig. 2, lane 6). In our im- 
munochemical study, H-FABP was observed in rat ovaries on 
postnatal day 3 [17]. These findings were confirmed at the RNA 
level, as assessed by Northern blot analysis (Fig. 3, lane 1). The 
ovarian 1-15P mRNA was not detected in immature rats, 
whereas H-FABP mRNA was significantly detected under the 
same conditions (Fig. 3, lane 4). Thus, the expression of rat 
I-15P is developmentally controlled in a tissue-specific manner. 
To gain further insight into the mechanism by which the 
ovarian I-15P gene is developmentally controlled, we examined 
the effect of gonadotropin treatment of immature rats on the 
expression of ovarian I- 15P. Western blot analysis revealed that 
no immunoreactive signal was observed for immature female 
rats (Fig. 2, lane 3), whereas a strong signal equivalent to that 
in mature rats (Fig. 2, lane 5) was detected in the cytosol derived 
from gonadotropin-treated immature rats (Fig. 2, lane 4). This 
finding suggests that the expression of ovarian I-15P is hormon- 
ally and developmentally controlled. 
To determine whether or not the regulation of the expression 
of ovarian 1-15P is correlated with that of the mRNA level, 
Northern blot analysis of total RNA from control and gona- 
dotropin-treated immature rats was performed (Fig. 3). The 
expression of ovarian 1-15P mRNA was also found to be in- 
duced by the hormone treatment (Fig. 3, lane 2), suggesting that 
the ovarian 1-15P gene expression might be controlled by the 
ovarian cycle at the transcriptional level. In fact, the expression 
of 1-15P in mature rats was shown to exclusively occur in 
corpus luteum cells of  ovaries [9,10]. On the other hand, the 
expression of H-FABP mRNA was not induced but markedly 
suppressed by the gonadotropin treatment (Fig. 3, lane 5). 
Thus, there is a remarkable difference in the regulation of the 
gene expression between I-15P and H-FABP during the ovarian 
development. Further study is required to elucidate the regula- 
tory mechanism of the tissue-specific gene expression of I-15P. 
We next examined if the 1-15P expression in the rat intestine 
is affected by gonadotropin treatment. As shown in Fig. 2, lanes 
1 and 2, no significant change in the protein level was observed 
in intestine, suggesting that the expression of I-15P in the intes- 
tine is independent of the ovarian cycle. 
More recently, it was shown that 1-15P isolated from rat or 
human ileum has the ability to bind to taurocholate, suggesting 
that taurocholate may be a specific ligand for I-15P in the ileum 
and that I-15P may be responsible for reabsorption of bile acids 
in this tissue [6, 7]. However, these findings raised a question 
regarding the function of 1-15P in extra-intestinal tissues, con- 
sidering its tissue distribution. As steroid hormones such as 
progesterone are synthesized from cholesterol and exhibit 
structural similarities to bile acids, they might be candidates for 
the ligands of I-15P in steroid hormone-producing tissues. Fur- 
ther study is required to clarify these issues. 
Overall, we conclude that the expression of I-15P is regulated 
in a tissue-specific manner, and that the function of 1-15P in 
extra-intestinal tissues might be different from that in the intes- 
tine. 
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